CompoAtlas

L-CITRULLINE 300g REKINKE

Food supplement declared in France, decision dated 24 March 2025

L-CITRULLINE 300g REKINKE, from REKINKE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: citrulline 3,000 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
REKINKE
Food business operator placing the product on the market
REKINKE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
3g
Directions for use
Diluer dans un verre d'eau ou de jus, votre shaker protéiné ou pré-workout 3 cuillères doseuses de 1g en 1 à 3 fois.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Sport

Declaration 256701, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
citrulline3,000 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : REKINKE

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “L-CITRULLINE 300g REKINKE: composition and regulation”, https://compoatlas.com/en/supplements/products/256701-l-citrulline-300g-rekinke, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line